Talphera, Inc. (NASDAQ:TLPH) Sees Significant Growth in Short Interest

Talphera, Inc. (NASDAQ:TLPH) was the recipient of a significant growth in short interest in March. As of March 15th, there was short interest totalling 104,100 shares, a growth of 42.4% from the February 28th total of 73,100 shares. Based on an average daily volume of 75,500 shares, the short-interest ratio is currently 1.4 days. Approximately 0.6% of the company’s stock are short sold.

Talphera Stock Down 5.5 %

Shares of TLPH opened at $0.59 on Friday. The firm has a market cap of $9.98 million, a price-to-earnings ratio of -0.85 and a beta of 0.20. The company’s fifty day moving average is $0.61 and its 200-day moving average is $0.71. Talphera has a 12 month low of $0.50 and a 12 month high of $1.27.

Analyst Ratings Changes

TLPH has been the subject of a number of research reports. HC Wainwright reissued a “buy” rating and set a $6.00 target price on shares of Talphera in a research note on Tuesday, January 21st. RODMAN&RENSHAW raised Talphera to a “strong-buy” rating in a research report on Tuesday, January 28th. Finally, Rodman & Renshaw began coverage on Talphera in a research report on Tuesday, January 28th. They issued a “buy” rating and a $4.00 target price on the stock.

Talphera Company Profile

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit.